Ex-Biopharma Exec Gets 2 Years For Admitting Insider Trades

By Alison Noon (June 20, 2018, 7:28 PM EDT) -- A Massachusetts federal judge on Wednesday sentenced a former executive at a California biopharmaceutical company to a below-guideline term of two years and three months in prison for admitting he traded in 2013 and 2014 on nonpublic information that trials of the company's prospective breast cancer treatment were showing positive results....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!